Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.

In the absence of point-of-care gonorrhea diagnostics that report antibiotic susceptibility, gonorrhea treatment is empiric and determined by standardized guidelines. These guidelines are informed by estimates of resistance prevalence from national surveillance systems. We examined whether guideline...

Full description

Bibliographic Details
Main Authors: Reza Yaesoubi, Ted Cohen, Katherine Hsu, Thomas L Gift, Sancta B St Cyr, Joshua A Salomon, Yonatan H Grad
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-02-01
Series:PLoS Computational Biology
Online Access:https://doi.org/10.1371/journal.pcbi.1009842
_version_ 1818273717356068864
author Reza Yaesoubi
Ted Cohen
Katherine Hsu
Thomas L Gift
Sancta B St Cyr
Joshua A Salomon
Yonatan H Grad
author_facet Reza Yaesoubi
Ted Cohen
Katherine Hsu
Thomas L Gift
Sancta B St Cyr
Joshua A Salomon
Yonatan H Grad
author_sort Reza Yaesoubi
collection DOAJ
description In the absence of point-of-care gonorrhea diagnostics that report antibiotic susceptibility, gonorrhea treatment is empiric and determined by standardized guidelines. These guidelines are informed by estimates of resistance prevalence from national surveillance systems. We examined whether guidelines informed by local, rather than national, surveillance data could reduce the incidence of gonorrhea and increase the effective lifespan of antibiotics used in treatment guidelines. We used a transmission dynamic model of gonorrhea among men who have sex with men (MSM) in 16 U.S. metropolitan areas to determine whether spatially adaptive treatment guidelines based on local estimates of resistance prevalence can extend the effective lifespan of hypothetical antibiotics. The rate of gonorrhea cases in these metropolitan areas was 5,548 cases per 100,000 MSM in 2017. Under the current strategy of updating the treatment guideline when the prevalence of resistance exceeds 5%, we showed that spatially adaptive guidelines could reduce the annual rate of gonorrhea cases by 200 cases (95% uncertainty interval: 169, 232) per 100,000 MSM population while extending the use of a first-line antibiotic by 0.75 (0.55, 0.95) years. One potential strategy to reduce the incidence of gonorrhea while extending the effective lifespan of antibiotics is to inform treatment guidelines based on local, rather than national, resistance prevalence.
first_indexed 2024-12-12T22:02:24Z
format Article
id doaj.art-e57b7e0afe0b491d8ff86b73fde0aa65
institution Directory Open Access Journal
issn 1553-734X
1553-7358
language English
last_indexed 2024-12-12T22:02:24Z
publishDate 2022-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Computational Biology
spelling doaj.art-e57b7e0afe0b491d8ff86b73fde0aa652022-12-22T00:10:28ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582022-02-01182e100984210.1371/journal.pcbi.1009842Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.Reza YaesoubiTed CohenKatherine HsuThomas L GiftSancta B St CyrJoshua A SalomonYonatan H GradIn the absence of point-of-care gonorrhea diagnostics that report antibiotic susceptibility, gonorrhea treatment is empiric and determined by standardized guidelines. These guidelines are informed by estimates of resistance prevalence from national surveillance systems. We examined whether guidelines informed by local, rather than national, surveillance data could reduce the incidence of gonorrhea and increase the effective lifespan of antibiotics used in treatment guidelines. We used a transmission dynamic model of gonorrhea among men who have sex with men (MSM) in 16 U.S. metropolitan areas to determine whether spatially adaptive treatment guidelines based on local estimates of resistance prevalence can extend the effective lifespan of hypothetical antibiotics. The rate of gonorrhea cases in these metropolitan areas was 5,548 cases per 100,000 MSM in 2017. Under the current strategy of updating the treatment guideline when the prevalence of resistance exceeds 5%, we showed that spatially adaptive guidelines could reduce the annual rate of gonorrhea cases by 200 cases (95% uncertainty interval: 169, 232) per 100,000 MSM population while extending the use of a first-line antibiotic by 0.75 (0.55, 0.95) years. One potential strategy to reduce the incidence of gonorrhea while extending the effective lifespan of antibiotics is to inform treatment guidelines based on local, rather than national, resistance prevalence.https://doi.org/10.1371/journal.pcbi.1009842
spellingShingle Reza Yaesoubi
Ted Cohen
Katherine Hsu
Thomas L Gift
Sancta B St Cyr
Joshua A Salomon
Yonatan H Grad
Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.
PLoS Computational Biology
title Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.
title_full Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.
title_fullStr Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.
title_full_unstemmed Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.
title_short Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.
title_sort evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics
url https://doi.org/10.1371/journal.pcbi.1009842
work_keys_str_mv AT rezayaesoubi evaluatingspatiallyadaptiveguidelinesforthetreatmentofgonorrheatoreducetheincidenceofgonococcalinfectionandincreasetheeffectivelifespanofantibiotics
AT tedcohen evaluatingspatiallyadaptiveguidelinesforthetreatmentofgonorrheatoreducetheincidenceofgonococcalinfectionandincreasetheeffectivelifespanofantibiotics
AT katherinehsu evaluatingspatiallyadaptiveguidelinesforthetreatmentofgonorrheatoreducetheincidenceofgonococcalinfectionandincreasetheeffectivelifespanofantibiotics
AT thomaslgift evaluatingspatiallyadaptiveguidelinesforthetreatmentofgonorrheatoreducetheincidenceofgonococcalinfectionandincreasetheeffectivelifespanofantibiotics
AT sanctabstcyr evaluatingspatiallyadaptiveguidelinesforthetreatmentofgonorrheatoreducetheincidenceofgonococcalinfectionandincreasetheeffectivelifespanofantibiotics
AT joshuaasalomon evaluatingspatiallyadaptiveguidelinesforthetreatmentofgonorrheatoreducetheincidenceofgonococcalinfectionandincreasetheeffectivelifespanofantibiotics
AT yonatanhgrad evaluatingspatiallyadaptiveguidelinesforthetreatmentofgonorrheatoreducetheincidenceofgonococcalinfectionandincreasetheeffectivelifespanofantibiotics